UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Total revenue	$ 570.8	$ 424.6	$ 1,125.5	$ 848.6
Total cost of revenue	290.2	238.4	566.2	470.1
Gross profit	280.6	186.2	559.3	378.5
Operating expenses:
Selling, general and administrative	134.8	102.4	266.6	223.6
Research and development	55.8	44.1	110.6	92.6
Other charges, net	4.4	1.8	7.4	8.0
Total operating expenses	195.0	148.3	384.6	324.2
Operating income	85.6	37.9	174.7	54.3
Interest and other income (expense), net	(5.6)	(6.6)	(9.4)	(9.5)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	80.0	31.3	165.3	44.8
Income tax provision	21.3	7.1	48.8	10.0
Consolidated net income	58.7	24.2	116.5	34.8
Net income attributable to noncontrolling interests in consolidated subsidiaries	1.1	0.1	2.2	0.2
Net income attributable to Bruker Corporation	$ 57.6	$ 24.1	$ 114.3	$ 34.6
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.38	$ 0.16	$ 0.75	$ 0.22
Diluted (in dollars per share)	$ 0.38	$ 0.16	$ 0.75	$ 0.22
Weighted average common shares outstanding:
Basic (in shares)	151.3	153.6	151.6	153.9
Diluted (in shares)	152.9	154.7	153.0	155.1
Comprehensive income	$ 73.4	$ 34.2	$ 115.0	$ 46.2
Less: Comprehensive (loss) income attributable to noncontrolling interests	(0.7)	0.3	0.2	0.2
Less: Comprehensive loss attributable to redeemable noncontrolling interest		0.0	0.0	(0.5)
Comprehensive income attributable to Bruker Corporation	74.1	33.9	114.8	46.5
Product
Total revenue	474.3	347.0	932.9	692.0
Total cost of revenue	236.0	193.3	456.9	373.8
Service
Total revenue	94.7	76.1	188.8	154.3
Total cost of revenue	54.1	44.7	108.8	95.8
Other
Total revenue	1.8	1.5	3.8	2.3
Total cost of revenue	$ 0.1	$ 0.4	$ 0.5	$ 0.5